Tags

Type your tag names separated by a space and hit enter

NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
Int J Clin Oncol. 2002 Apr; 7(2):103-8.IJ

Abstract

BACKGROUND

NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T was reportedly associated with leukemia, lung cancer, colorectal cancer, and urological malignancies. This study was conducted to screen possible cancer sites associated with this polymorphism by a prevalent case-control design.

METHODS

The cases were 102 patients with esophageal cancer, 143 with stomach cancer, 74 with colon cancer, 72 with rectal cancer, 192 with lung cancer, 237 with breast cancer, 56 with prostate cancer, and 108 with malignant lymphoma. Controls consisted of outpatients from two sources: 241 noncancer outpatients who underwent gastroscopy and 399 first-visit outpatients, expected to include about 20% with cancer. Genotyping was conducted by polymerase chain reaction with confronting two-pair primers (PCR-CTPP).

RESULTS

The TT genotype with null enzyme activity was found in 19.9% of the 241 noncancer gastroscopy examinees, 16.5% of the 399 first-visit outpatients, 12.7% of the esophageal cancer patients, 16.8% of the stomach cancer patients, 13.5% of the colon cancer patients, 9.7% of the rectal cancer patients, 17.7% of the lung cancer patients, 14.3% of the breast cancer patients, 16.1% of the prostate cancer patients, and 15.7% of the malignant lymphoma patients. The odds ratios (ORs) of the genotypes were not significant for any cancers combined or for any site of cancer, except for lung cancer (OR, 0.66; 95% confidence interval [CI], 0.46-0.96 for CT relative to CC). The OR of current smoking for cancers of the esophagus and lung combined was different between the CC genotype (OR, 2.06; 95% CI, 1.06-3.98) and TT genotype (OR, 5.11; 95% CI, 1.37-19.05), although the difference was not significant.

CONCLUSION

This study suggests that the CC genotype of the NQO1 C609T polymorphism is associated with the risk of lung cancer, and that the TT genotype increases the risk of smoking for cancers of the esophagus and lung.

Authors+Show Affiliations

Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan. nhamajim@aichi-cc.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

12018106

Citation

Hamajima, Nobuyuki, et al. "NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism and the Risk of Eight Cancers for Japanese." International Journal of Clinical Oncology, vol. 7, no. 2, 2002, pp. 103-8.
Hamajima N, Matsuo K, Iwata H, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7(2):103-8.
Hamajima, N., Matsuo, K., Iwata, H., Shinoda, M., Yamamura, Y., Kato, T., Hatooka, S., Mitsudomi, T., Suyama, M., Kagami, Y., Ogura, M., Ando, M., Sugimura, Y., & Tajima, K. (2002). NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. International Journal of Clinical Oncology, 7(2), 103-8.
Hamajima N, et al. NAD(P)H: Quinone Oxidoreductase 1 (NQO1) C609T Polymorphism and the Risk of Eight Cancers for Japanese. Int J Clin Oncol. 2002;7(2):103-8. PubMed PMID: 12018106.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. AU - Hamajima,Nobuyuki, AU - Matsuo,Keitaro, AU - Iwata,Hiroji, AU - Shinoda,Masayuki, AU - Yamamura,Yoshitaka, AU - Kato,Tomoyuki, AU - Hatooka,Shunzo, AU - Mitsudomi,Tetsuya, AU - Suyama,Motokazu, AU - Kagami,Yoshitoyo, AU - Ogura,Michinori, AU - Ando,Manabu, AU - Sugimura,Yoshiki, AU - Tajima,Kazuo, PY - 2002/5/23/pubmed PY - 2002/11/26/medline PY - 2002/5/23/entrez SP - 103 EP - 8 JF - International journal of clinical oncology JO - Int J Clin Oncol VL - 7 IS - 2 N2 - BACKGROUND: NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T was reportedly associated with leukemia, lung cancer, colorectal cancer, and urological malignancies. This study was conducted to screen possible cancer sites associated with this polymorphism by a prevalent case-control design. METHODS: The cases were 102 patients with esophageal cancer, 143 with stomach cancer, 74 with colon cancer, 72 with rectal cancer, 192 with lung cancer, 237 with breast cancer, 56 with prostate cancer, and 108 with malignant lymphoma. Controls consisted of outpatients from two sources: 241 noncancer outpatients who underwent gastroscopy and 399 first-visit outpatients, expected to include about 20% with cancer. Genotyping was conducted by polymerase chain reaction with confronting two-pair primers (PCR-CTPP). RESULTS: The TT genotype with null enzyme activity was found in 19.9% of the 241 noncancer gastroscopy examinees, 16.5% of the 399 first-visit outpatients, 12.7% of the esophageal cancer patients, 16.8% of the stomach cancer patients, 13.5% of the colon cancer patients, 9.7% of the rectal cancer patients, 17.7% of the lung cancer patients, 14.3% of the breast cancer patients, 16.1% of the prostate cancer patients, and 15.7% of the malignant lymphoma patients. The odds ratios (ORs) of the genotypes were not significant for any cancers combined or for any site of cancer, except for lung cancer (OR, 0.66; 95% confidence interval [CI], 0.46-0.96 for CT relative to CC). The OR of current smoking for cancers of the esophagus and lung combined was different between the CC genotype (OR, 2.06; 95% CI, 1.06-3.98) and TT genotype (OR, 5.11; 95% CI, 1.37-19.05), although the difference was not significant. CONCLUSION: This study suggests that the CC genotype of the NQO1 C609T polymorphism is associated with the risk of lung cancer, and that the TT genotype increases the risk of smoking for cancers of the esophagus and lung. SN - 1341-9625 UR - https://www.unboundmedicine.com/medline/citation/12018106/NAD_P_H:_quinone_oxidoreductase_1__NQO1__C609T_polymorphism_and_the_risk_of_eight_cancers_for_Japanese_ L2 - http://dx.doi.org/10.1007/s101470200013 DB - PRIME DP - Unbound Medicine ER -